Syngene International appoints Dr Rohtash Kumar as Head of CDMO, Small and Large Molecule

Rohtash is an established pharmaceutical operations leader with over two decades of experience in R&D, manufacturing, and executive leadership across global CDMO organizations. Most recently, he led Global Technology and Development at Veranova, where he drove innovation in APIs, including small molecules, peptides, oligonucleotides, and biologics. His efforts successfully advanced branded API molecules to market in collaboration with biotech partners. He also worked at

Bachem Americas, Inc., Sigma-Aldrich, Toronto Research Chemicals, and Apotex Inc.

A prolific researcher, Rohtash holds multiple patents and publications to his name. He earned his Ph.D. in Organic Chemistry from the University of Delhi, an M.Sc. in Organic Chemistry, and an MBA from Chaudhary Charan Singh University. Additionally, he is a member of the American, Canadian, and Indian Medical Societies.